GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

The FDA’s Oncologic Drugs Advisory Committee has voted against the benefit/risk profile of GSK’s Blenrep just days before the drug’s PDUFA date.

European shares rose on Friday, on course for small weekly gains, as investors focussed on corporate earnings for clues on ...

The growth impact may be compounded over time as slower population growth—or shrinking populations—leads to fewer new ideas and inventions that power long-term productivity growth. Second, people’s ...

Irish Ferries brand owner Irish Continental Group was the strongest performer on the index, closing up 1.44 per cent to €5.64 ...

The UK's FTSE 100 surpassed the 9,000-point mark for the first time on Tuesday, as investors took comfort in a relatively ...

GSK plc’s GSK Specialty Medicines segment includes medicines that prevent and treat diseases like HIV, cancer, asthma and immune-inflammation diseases like lupus. Specialty Medicines now represents ...

MorganFranklin Cyber announces promotion of two longtime leaders to newly created roles designed to support strategic growth & client-centric mission.

Despite all the drama, trade uncertainty hasn't really hurt economic growth, Goldman Sachs says By Huileng Tan ...